Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The emergence of resistance to former first-line antimalarial drugs has been an unmitigated disaster. In recent years, artemisinin class drugs have become standard and they are considered an essential tool for helping to eradicate the disease. However, their ability to reduce morbidity and mortality and to slow transmission requires the maintenance of effectiveness. Recently, an artemisinin delayed-clearance phenotype was described. This is believed to be the precursor to resistance and threatens local elimination and global eradication plans. Understanding how resistance emerges and spreads is important for developing strategies to contain its spread. Resistance is the result of two processes: (i) drug selection of resistant parasites; and (ii) the spread of resistance. In this review, we examine the factors that lead to both drug selection and the spread of resistance. We then examine strategies for controlling the spread of resistance, pointing out the complexities and deficiencies in predicting how resistance will spread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 11×
“Thus, unsurprisingly, P. falciparum parasites with reduced in vivo susceptibility to artemisinin derivatives were first reported in 2008 in western Cambodia [50,74].”
BackgroundInfluentialGlobal malaria mortality between 1980 and 2010: a systematic analysis
Murray, C. J., Rosenfeld, L. C., Lim, S. S., Andrews, K. G., Foreman, K. J., Haring, D., Fullman, N., Naghavi, M., Lozano, R., & Lopez, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60034-8 · Cited by 1,452 · cited 1×
“Malaria is the most important parasite of humans, affecting more than 2 billion people and causing hundreds of millions of clinical cases of malaria every year [1,2].”
BackgroundWoolhouse, M. E. J., Dye, C., Etard, J.-F., Smith, T., Charlwood, J. D., Garnett, G. P., Hagan, P., Hii, J. L. K., Ndhlovu, P. D., Quinnell, R. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.338 · Cited by 1,194
Ross, Macdonald, and a Theory for the Dynamics and Control of Mosquito-Transmitted Pathogens
Smith, D. L., Battle, K. E., Hay, S. I., Barker, C. M., Scott, T. W., & McKenzie, F. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002588 · Cited by 631
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67669-6 · Cited by 412
The entomological inoculation rate and Plasmodium falciparum infection in African children
Smith, D. L., Dushoff, J., Snow, R. W., & Hay, S. I. (2005) · Nature · doi:10.1038/nature04024 · Cited by 369 · cited 2×
“20% of the individuals receiving 80% of the bites [27,120,121].”
BackgroundMosquito (Diptera: Culicidae) Dispersal—The Long and Short of it
Service, M. W. (1997) · Journal of Medical Entomology · doi:10.1093/jmedent/34.6.579 · Cited by 256
Wanji, S., Tanke, T., Atanga, S. N., Ajonina, C., Nicholas, T., & Fontenille, D. (2003) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2003.01070.x · Cited by 135
Pandemic (H1N1) 2009 and Seasonal Influenza A (H1N1) Co-infection, New Zealand, 2009
Peacey, M., Hall, R. J., Sonnberg, S., Ducatez, M., Paine, S., Nicol, M., Ralston, J. C., Bandaranayake, D., Hope, V., Webby, R. J., et al. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1610.100116 · Cited by 53
Cited by
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
Antimalarial drug resistance: An overview
Parija, S., & Antony, H. (2016) · Tropical Parasitology · doi:10.4103/2229-5070.175081 · Cited by 215
“[1,2] However, the therapeutic efficacy of CQ and efforts to eradicate malaria worldwide were diminished due to the occurrence of CQ resistance.”
Malaria ecology along the Thailand-Myanmar border.
Parker, D. M., Carrara, V. I., Pukrittayakamee, S., McGready, R., & Nosten, F. H. (2015) · Malaria Journal · doi:10.1186/s12936-015-0921-y · Cited by 142
“A similar scenario can explain the spread of drug-resistant strains [16, 27, 106, 107].”
BackgroundUsher, J., & Haynes, K. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008259 · Cited by 27
“Drug resistance has emerged as a huge problem in many areas of medicine from cancer to infectious diseases [1, 2, 3, 4].”
BackgroundRecasting the theory of mosquito-borne pathogen transmission dynamics and control
Smith, D. L., Perkins, T. A., Reiner, R. C., Barker, C. M., Niu, T., Chaves, L. F., Ellis, A. M., George, D. B., Le Menach, A., Pulliam, J. R. C., et al. (2014) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/tru026 · Cited by 190
“…control 48–50 ; transmission or disease control with drugs or vaccines 51–54 ; pathogen evolution and the management of virulence or drug resistance 55 ; two or more pathogens and facilitation or competition 54,56 ; genetic manipulation of mosquitoes or the evolution of insecticide resistance…”
BackgroundSelf-citation
Metadata
- Authors
- Klein, E. Y.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 41
- Issue
- 4
- Pages
- 311-317
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2133236892
- Cited by
- 155
- References
- 9
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.